Closed Health
ImmUniverse

Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

€31MFunding
78Months
29Partners

Fact sheet

Programme
Horizon 2020 & sub-programmes
Companies
EURICE
Duration
78 months (January 2020 – June 2026)
Project funding
€ 31,000,000.00
Project partners
29
Technology readiness level
0-2
Project website
https://www.immuniverse.eu

About the project

By looking into the common disease mechanisms of Ulcerative Colitis and Atopic Dermatitis, ImmUniverse aims at improving diagnostic and therapeutic options for patients living with both conditions. Through molecular profiling techniques, the consortium will identify signatures of biomarkers and mechanistic principles which reveal information on disease severity and progression enabling personalised therapy decisions for each patient at the right time.

Coordinator

Prof. Stefania Vetrano
Humanitas University, Milan, Italy
Email coordinator